# Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.

> **NCT07040930** · PHASE1 · RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 30 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** GenSci120
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07040930
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-07-05
- **Final completion:** 2026-09-20
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07040930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07040930, "Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07040930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*